A potential CSF marker of a specific tau pathology that has been very recently studied is a 4-repeat isoform-specific tau species from the microtubule-binding region (MTBR-tau) – an initial study shows a decrease in people with corticobasal degeneration (a primary tauopathy), as well as those with AD [6]. This evidence concerns the gene MAPT and Alzheimer disease.